Analysts expect Arbutus Biopharma Corp to report revenue of 1.04 M for Q3 26, against a range of 1.00 M to 1.09 M. The most recent reported quarter, Q2 26, came in at 1.01 M, a 40.3% beat against the 719,873.00 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.34 M | 1.57 M | 1.76 M | 10.74 M | 529,000.00 | 1.05 M | 179.13 M | 1.01 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.93 M | 1.79 M | 1.73 M | 1.69 M | 1.41 M | 679,057.50 | 831,663.94 | 777,695.36 | 1.09 M | 1.02 M | 1.11 M | 1.00 M | 498,961.72 | 434,615.45 | 13.49 M | 26.19 M | ||||||||||
| Low Estimate | 1.61 M | 1.54 M | 1.58 M | 1.57 M | 1.24 M | 634,608.30 | 759,716.06 | 662,050.64 | 1.00 M | 861,388.69 | 1.00 M | 938,989.95 | 442,299.66 | 380,519.05 | 12.28 M | 22.10 M | ||||||||||
| Consensus Estimate | 1.77 M | 1.66 M | 1.66 M | 1.63 M | 1.32 M | 656,832.90 | 795,690.00 | 719,873.00 | 1.04 M | 941,465.00 | 1.06 M | 971,825.00 | 470,630.69 | 407,567.25 | 12.88 M | 24.15 M |
Analysts expect Arbutus Biopharma Corp to report earnings per share of -0.02 for Q3 26, against a range of -0.02 to -0.02. The most recent reported quarter, Q2 26, came in at -0.03, a 50.0% miss against the -0.02 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.10 | -0.07 | -0.13 | 0.01 | -0.04 | -0.01 | 0.87 | -0.03 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.08 | -0.09 | -0.09 | -0.05 | -0.03 | -0.04 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.10 | -0.11 | 0.08 | -0.06 | ||||||||||
| Low Estimate | -0.10 | -0.09 | -0.11 | -0.05 | -0.03 | -0.04 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.12 | -0.13 | 0.08 | -0.08 | ||||||||||
| Consensus Estimate | -0.09 | -0.09 | -0.10 | -0.05 | -0.03 | -0.04 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.11 | -0.12 | 0.08 | -0.07 |
Pull Wall Street consensus for Arbutus Biopharma Corp (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ABUS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ABUS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ABUS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();